Updated August 28, 2015 This content is archived.
Jeffrey P. Johnson, MD, division director of obstetrics and gynecology, and a team of doctors at Women and Children's Hospital of Buffalo, successfully used a novel treatment on a 32-week-old fetus with a rare congenial abnormality known as fetal hydrothorax. The condition is so rare it is unlikely a clinical trial comparing their use of doxycycline to standard therapy will ever occur.
No events scheduled.